New study: Imoferaza^® improves prognosis of complex scar therapy

Topical skin care using different scar treatment methods was examined in a new study published in the journal Effective Pharmacotherapy.

Scars and marks are a factor that seriously reduces the quality of life of patients^[1]. They affect self-esteem, choice of clothing, communication, and sex life.

To combat this problem, complex therapy is proposed, including hardware techniques, radiation therapy, and drug treatment. Achieving the best results is based on following the treatment schedule and proper skin care between treatments. The medications prescribed during this period should be well tolerated and not cause side effects.

Complex protocols for scar therapy include hyaluronidase in injection form^[2]. To achieve a more lasting and pronounced result, it can also be prescribed in topical form for external use^[3].

According to a new study^[4] of conjugated hyaluronidase, which is part of the cosmetic cream Imoferaza^®, in complex therapy, the indicators of scar thickness, its relief, color and elasticity improved by more than 70%. According to 95% of study participants, the use of Imoferaza^® cream helps to reduce scarring.

In addition, patients during the study noted that the use of the cream reduced the unpleasant sensations associated with certain hardware procedures, such as burning, dryness, tightness, and redness of the skin.

Imoferaza^® is an innovative product based on the immobilized enzyme hyaluronidase for specialized care of problem areas and areas of skin altered by scars after cosmetic procedures, injuries, burns, acne (post-acne), and operations.

The cream contains a prolonged-action enzyme that is resistant to tissue hyaluronidase inhibitors and therefore retains its activity for a longer period of time.

The cream can now be purchased in pharmacies in new packaging. Increasing its volume to 90 g makes it easier to care for large scars.